Submitting OIG:
Report Description:
For a covered outpatient drug to be eligible for Federal reimbursement under the Medicaid program's drug rebate requirements, manufacturers must pay rebates to the States for the drugs. However, a prior OIG review found that States did not always invoice and collect all rebates due for drugs administered by physicians.
Date Issued:
Wednesday, November 1, 2017
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-05-16-00013
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
OH
United StatesType of Report:
Audit
Questioned Costs:
$22,332,999
Funds for Better Use:
$0
Number of Recommendations:
7
View Document:
Attachment | Size |
---|---|
51600013.pdf | 666.49 KB |
Additional Details Link: